Schedule 13D ownership disclosure

PetLife Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 71639B105

Event date: 2014-08-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
26,754,940
Percent of class
46.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001360865-14-000048
Form type
SC 13D
Filer
Mikaelian Arthur G.
CIK
CIK 1619972
Filed
Sep 29, 2014
Reporting period
Aug 11, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub